about
Interventions for pemphigus vulgaris and pemphigus foliaceusManagement of pemphigus vulgaris: challenges and solutionsPreliminary data on Pemphigus vulgaris treatment by a proteomics-defined peptide: a case report.Counseling in Pemphigus.Shifting Focus in the Therapeutics of Immunobullous Disease.Azathioprine-induced pancytopenia in a patient with pompholyx and deficiency of erythrocyte thiopurine methyltransferaseAssociation between HLA-DRB1 polymorphisms and pemphigus vulgaris: a meta-analysisThe influence of corticosteroid treatment on the OPG/RANK/RANKL pathway and osteocalcin in patients with pemphigus.Guidelines on the use of extracorporeal photopheresisVitamin D and skeletal health in autoimmune bullous skin diseases: a case control studyPemphigus vulgaris--a report of three casesRituximab therapy improves recalcitrant Pemphigus vulgaris.The management of oral pemphigus vulgaris with systemic corticosteroid and dapsone.Oral Pemphigus Vulgaris: Case Report.Effect of intravenous immunoglobulin on prednisone dose in patients with pemphigus vulgaris.Comparative study of the prevalence of sepsis in patients admitted to dermatology and internal medicine wardsAssessing the Autoantibody levels in Relation to Recurrence of Pemphigus: Joint Modeling of Longitudinal Measurements and Recurrent Event Times.Pharmacokinetic evaluation of mycophenolate mofetil for pemphigus.The diagnosis and treatment of autoimmune blistering skin diseases.Urban legends: pemphigus vulgaris.Cytokine networks in Pemphigus vulgaris: An integrated viewpoint.Diagnosis and treatment of pemphigus.Systemic use of non-biologic corticosteroids in orofacial diseases.Systemic use of non-biologics in orofacial diseases: 2. Purine synthesis inhibitors.Mycophenolate mofetil and enteric-coated mycophenolate sodium in the treatment of pemphigus vulgaris and pemphigus foliaceus.Vesiculobullous disorders affecting the oral cavity.Accelerating effects of epidermal growth factor on skin lesions of pemphigus vulgaris: a double-blind, randomized, controlled trial.A clinical audit of high-cost and off-label drug use in dermatology.Ocular involvement in pemphigus vulgaris - a retrospective study of a large Spanish cohort.Pemphigus vulgaris: a rare cause of dysphagia.Cassia fistula: A remedy from Traditional Persian Medicine for treatment of cutaneous lesions of pemphigus vulgaris.Unusual Histological Evidence of Dysplasia in a Case of Oral Pemphigus Vulgaris: A Potential Diagnostic Challenge.Comparative study of indirect immunofluorescence, enzyme-linked immunosorbent assay, and the Tzanck smear test for the diagnosis of pemphigus.Oral mucous membrane pemphigoid and pemphigus vulgaris-a retrospective two-center cohort study.Successful treatment of pemphigus vulgaris with the extensive mucocutaneous lesions in an elderly patient.Epidemiology of pemphigus in the western region of Turkey: retrospective analysis of 87 patients.Comparison of desmoglein 1 and 3 enzyme-linked immunosorbent assay and direct immunofluorescence for evaluation of immunological remission in pemphigus vulgaris.Adjuvant rituximab therapy in pemphigus: a single-center experience of 18 cases.Impact of smoking on pemphigus.Outcome of pemphigus vulgaris.
P2860
Q24241277-ACD28A6F-5A6E-4A59-954C-3F5AE34A61E4Q26778895-4C283E32-A0D4-4576-BB13-225CBDDFC280Q31069812-E1096332-4165-430D-A2E6-0C49F5E21C91Q33737970-6E7E0130-17CD-49C3-A28F-287157B5AF19Q33737974-F7340601-289B-4E1E-ABD0-0BE723569066Q33842949-F890FCA2-F638-441E-8A55-A80CFD49DF95Q34260384-2455B955-1F01-4D77-B1BB-E81969E760A1Q34457946-E62B0681-FEAE-4517-B69E-D226D0691F1EQ34918643-6A797407-1739-4015-9322-B8162F4430E4Q35068151-BCD161E5-3DDB-46A3-BA98-4FF4BCBF4DB6Q35863671-D4725D49-7005-4B9B-8738-214B4FD537BFQ36008711-9B51D97E-44A0-4FF2-9021-7289743D8635Q36498277-C3499F49-DB82-4857-A1AC-38BE64DFB82DQ36605322-44A7CC33-ABB3-413A-9B1B-49320888B016Q36711706-0DBB2224-EB68-4E37-8199-D4B6E042074BQ37233747-BD5DE258-A11A-4707-9961-D83D80B23A35Q37663332-AAA28345-7334-454C-B6ED-15181B1E87ECQ37824708-B864D574-0E12-4F4F-B27D-9F13F9C581C6Q37895468-C802E5A9-7A90-4942-894F-DEAE5D63F675Q37984131-047ACAD6-842A-4966-90F5-F6963C11F6D1Q38017731-A80AF698-937B-4EC1-9B24-408D0FBD98EEQ38031283-15FE91A7-13DA-4A8F-8D3F-AD360238A293Q38112826-7F79E9BC-EBE8-423F-94F2-51E284ABEB54Q38120321-774B7A9A-D171-4B1A-94AF-C45822E452EEQ38187458-E54112D4-FB0D-4662-A227-BF68B05A70B9Q38248664-8EEB1725-02A0-4DBF-B203-8F58FFAE9A09Q38400661-5CBB944F-3A24-4931-98A0-F9412662C2DBQ38582166-85F1E0F3-425C-4C0F-99DF-9AF62EAB0FB0Q38884157-9AD1B365-F849-4BDA-AF2A-582C2F792862Q39181749-6D8C1D46-8B9B-4726-90F3-33BB5B5B734AQ39203935-453DF252-D068-4139-9668-7946188DB0DAQ39681274-87F2B317-1D21-42D7-B66F-E6D7B0811C1BQ39896897-1E59E587-E122-493B-813A-A1B4B823B462Q40373342-DFD0D9F0-6FD8-4054-B55F-D765444304A0Q42086382-F82458A8-5F41-488E-ABBB-84D61387C1B5Q44076683-B7B7328C-C3F6-4312-81D5-241A732E04CDQ45097996-C67AD5D5-41A3-4645-84C5-E959D78DF9D0Q45117048-AC2DE266-B7B2-4C80-8840-946D6BD77B1DQ46598214-E2A7A910-6938-43B6-A2C5-49E5130CBD03Q46808919-FCE1A6C4-F07B-489C-B188-A7E99901DB63
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Guidelines for the management of pemphigus vulgaris.
@en
Guidelines for the management of pemphigus vulgaris.
@nl
type
label
Guidelines for the management of pemphigus vulgaris.
@en
Guidelines for the management of pemphigus vulgaris.
@nl
prefLabel
Guidelines for the management of pemphigus vulgaris.
@en
Guidelines for the management of pemphigus vulgaris.
@nl
P2093
P2860
P1476
Guidelines for the management of pemphigus vulgaris.
@en
P2093
British Association of Dermatologists
K E Harman
P2860
P304
P356
10.1111/J.1365-2133.2003.05665.X
P407
P577
2003-11-01T00:00:00Z